COURSERA INC (COUR) Fundamental Analysis & Valuation

NYSE:COUR • US22266M1045

Current stock price

5.36 USD
-0.24 (-4.29%)
At close:
5.41 USD
+0.05 (+0.93%)
After Hours:

This COUR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. COUR Profitability Analysis

1.1 Basic Checks

  • In the past year COUR was profitable.
  • In the past year COUR had a positive cash flow from operations.
  • In the past 5 years COUR always reported negative net income.
  • COUR had a positive operating cash flow in 4 of the past 5 years.
COUR Yearly Net Income VS EBIT VS OCF VS FCFCOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M -150M

1.2 Ratios

  • COUR's Return On Assets of -5.10% is on the low side compared to the rest of the industry. COUR is outperformed by 64.38% of its industry peers.
  • Looking at the Return On Equity, with a value of -8.02%, COUR is in line with its industry, outperforming 47.95% of the companies in the same industry.
Industry RankSector Rank
ROA -5.1%
ROE -8.02%
ROIC N/A
ROA(3y)-8.77%
ROA(5y)-11.99%
ROE(3y)-13.42%
ROE(5y)-17.02%
ROIC(3y)N/A
ROIC(5y)N/A
COUR Yearly ROA, ROE, ROICCOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30

1.3 Margins

  • The Gross Margin of COUR (54.57%) is better than 65.75% of its industry peers.
  • In the last couple of years the Gross Margin of COUR has remained more or less at the same level.
  • COUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.82%
GM growth 5Y0.7%
COUR Yearly Profit, Operating, Gross MarginsCOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

7

2. COUR Health Analysis

2.1 Basic Checks

  • COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for COUR has been increased compared to 1 year ago.
  • Compared to 5 years ago, COUR has more shares outstanding
  • There is no outstanding debt for COUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
COUR Yearly Shares OutstandingCOUR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
COUR Yearly Total Debt VS Total AssetsCOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • COUR has an Altman-Z score of 1.37. This is a bad value and indicates that COUR is not financially healthy and even has some risk of bankruptcy.
  • COUR's Altman-Z score of 1.37 is in line compared to the rest of the industry. COUR outperforms 58.90% of its industry peers.
  • COUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.37
ROIC/WACCN/A
WACC8.95%
COUR Yearly LT Debt VS Equity VS FCFCOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • COUR has a Current Ratio of 2.51. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.
  • COUR has a Current ratio of 2.51. This is amongst the best in the industry. COUR outperforms 83.56% of its industry peers.
  • A Quick Ratio of 2.51 indicates that COUR has no problem at all paying its short term obligations.
  • COUR's Quick ratio of 2.51 is amongst the best of the industry. COUR outperforms 84.93% of its industry peers.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 2.51
COUR Yearly Current Assets VS Current LiabilitesCOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

5

3. COUR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 17.65% over the past year.
  • The Revenue has grown by 9.04% in the past year. This is quite good.
  • Measured over the past years, COUR shows a very strong growth in Revenue. The Revenue has been growing by 20.88% on average per year.
EPS 1Y (TTM)17.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
Revenue 1Y (TTM)9.04%
Revenue growth 3Y13.09%
Revenue growth 5Y20.88%
Sales Q2Q%9.89%

3.2 Future

  • Based on estimates for the next years, COUR will show a very strong growth in Earnings Per Share. The EPS will grow by 24.40% on average per year.
  • COUR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.50% yearly.
EPS Next Y11.5%
EPS Next 2Y16.98%
EPS Next 3Y24.4%
EPS Next 5YN/A
Revenue Next Year8.02%
Revenue Next 2Y7.21%
Revenue Next 3Y5.5%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COUR Yearly Revenue VS EstimatesCOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
COUR Yearly EPS VS EstimatesCOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4 0.6

5

4. COUR Valuation Analysis

4.1 Price/Earnings Ratio

  • COUR is valuated correctly with a Price/Earnings ratio of 13.40.
  • Based on the Price/Earnings ratio, COUR is valued a bit cheaper than 72.60% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of COUR to the average of the S&P500 Index (26.78), we can say COUR is valued slightly cheaper.
  • COUR is valuated correctly with a Price/Forward Earnings ratio of 12.02.
  • Based on the Price/Forward Earnings ratio, COUR is valued cheaply inside the industry as 82.19% of the companies are valued more expensively.
  • COUR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.54.
Industry RankSector Rank
PE 13.4
Fwd PE 12.02
COUR Price Earnings VS Forward Price EarningsCOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 79.45% of the companies in the same industry are more expensive than COUR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.56
EV/EBITDA N/A
COUR Per share dataCOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • COUR's earnings are expected to grow with 24.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.16
PEG (5Y)N/A
EPS Next 2Y16.98%
EPS Next 3Y24.4%

0

5. COUR Dividend Analysis

5.1 Amount

  • No dividends for COUR!.
Industry RankSector Rank
Dividend Yield 0%

COUR Fundamentals: All Metrics, Ratios and Statistics

COURSERA INC

NYSE:COUR (4/10/2026, 8:14:45 PM)

After market: 5.41 +0.05 (+0.93%)

5.36

-0.24 (-4.29%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)02-05
Earnings (Next)04-23
Inst Owners92.06%
Inst Owner Change0.2%
Ins Owners5.14%
Ins Owner Change1.08%
Market Cap907.50M
Revenue(TTM)757.50M
Net Income(TTM)-51.00M
Analysts76.47
Price Target9.82 (83.21%)
Short Float %17.01%
Short Ratio4.87
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.68%
Min EPS beat(2)-1.96%
Max EPS beat(2)17.31%
EPS beat(4)3
Avg EPS beat(4)25.3%
Min EPS beat(4)-1.96%
Max EPS beat(4)49.74%
EPS beat(8)7
Avg EPS beat(8)297.92%
EPS beat(12)11
Avg EPS beat(12)902.16%
EPS beat(16)14
Avg EPS beat(16)684.85%
Revenue beat(2)2
Avg Revenue beat(2)0.33%
Min Revenue beat(2)0.03%
Max Revenue beat(2)0.63%
Revenue beat(4)4
Avg Revenue beat(4)0.62%
Min Revenue beat(4)0.03%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.01%
Revenue beat(12)9
Avg Revenue beat(12)0.91%
Revenue beat(16)12
Avg Revenue beat(16)0.69%
PT rev (1m)-2.78%
PT rev (3m)-17.93%
EPS NQ rev (1m)1.46%
EPS NQ rev (3m)-26.84%
EPS NY rev (1m)1.51%
EPS NY rev (3m)-2.52%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)2.02%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)1.91%
Valuation
Industry RankSector Rank
PE 13.4
Fwd PE 12.02
P/S 1.2
P/FCF 11.56
P/OCF 8.35
P/B 1.43
P/tB 1.49
EV/EBITDA N/A
EPS(TTM)0.4
EY7.46%
EPS(NY)0.45
Fwd EY8.32%
FCF(TTM)0.46
FCFY8.65%
OCF(TTM)0.64
OCFY11.98%
SpS4.47
BVpS3.75
TBVpS3.59
PEG (NY)1.16
PEG (5Y)N/A
Graham Number5.81
Profitability
Industry RankSector Rank
ROA -5.1%
ROE -8.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.57%
FCFM 10.36%
ROA(3y)-8.77%
ROA(5y)-11.99%
ROE(3y)-13.42%
ROE(5y)-17.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.82%
GM growth 5Y0.7%
F-Score6
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 104.86%
Cap/Sales 3.99%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.51
Quick Ratio 2.51
Altman-Z 1.37
F-Score6
WACC8.95%
ROIC/WACCN/A
Cap/Depr(3y)115.48%
Cap/Depr(5y)105.87%
Cap/Sales(3y)4.2%
Cap/Sales(5y)3.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
EPS Next Y11.5%
EPS Next 2Y16.98%
EPS Next 3Y24.4%
EPS Next 5YN/A
Revenue 1Y (TTM)9.04%
Revenue growth 3Y13.09%
Revenue growth 5Y20.88%
Sales Q2Q%9.89%
Revenue Next Year8.02%
Revenue Next 2Y7.21%
Revenue Next 3Y5.5%
Revenue Next 5YN/A
EBIT growth 1Y24.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year172.48%
EBIT Next 3Y69.69%
EBIT Next 5YN/A
FCF growth 1Y32.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.99%
OCF growth 3YN/A
OCF growth 5YN/A

COURSERA INC / COUR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of COURSERA INC (COUR) stock?

ChartMill assigns a fundamental rating of 4 / 10 to COUR.


What is the valuation status of COURSERA INC (COUR) stock?

ChartMill assigns a valuation rating of 5 / 10 to COURSERA INC (COUR). This can be considered as Fairly Valued.


Can you provide the profitability details for COURSERA INC?

COURSERA INC (COUR) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for COUR stock?

The Price/Earnings (PE) ratio for COURSERA INC (COUR) is 13.4 and the Price/Book (PB) ratio is 1.43.


How financially healthy is COURSERA INC?

The financial health rating of COURSERA INC (COUR) is 7 / 10.